CO.DON - successful conclusion of Phase II trial “co.dis” demonstrates efficacy and safety of the EU-authorised pharmaceutical product Spherox
After five years of follow-up observation, CO.DON AG has brought the Phase II clinical trial “co.dis” to a successful close. In the long-term clinical study 75 patients aged between 18 and 50, with cartilage defects in the knee, were treated with the…